These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 22932788)
21. Retroperitoneal liposarcoma: MR characteristics and pathological correlative analysis. Song T; Shen J; Liang BL; Mai WW; Li Y; Guo HC Abdom Imaging; 2007; 32(5):668-74. PubMed ID: 17387533 [TBL] [Abstract][Full Text] [Related]
22. Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Corradi D; Maestri R; Palmisano A; Bosio S; Greco P; Manenti L; Ferretti S; Cobelli R; Moroni G; Dei Tos AP; Buzio C; Vaglio A Kidney Int; 2007 Sep; 72(6):742-53. PubMed ID: 17622270 [TBL] [Abstract][Full Text] [Related]
23. Metastasis--an unusual cause of retroperitoneal fibrosis. Sadhu A; Sen S; Seal S; Sharma SK J Indian Med Assoc; 2006 Nov; 104(11):642, 644. PubMed ID: 17444067 [TBL] [Abstract][Full Text] [Related]
24. Tumor-forming idiopathic retroperitoneal fibrosis: report of a case. Takashima T; Onoda N; Ishikawa T; Koyama T; Inaba M; Nishizawa Y; Nakatani T; Wakasa K; Hirakawa K Surg Today; 2004; 34(4):374-8. PubMed ID: 15052458 [TBL] [Abstract][Full Text] [Related]
25. Persistent FDG/PET CT uptake in idiopathic retroperitoneal fibrosis helps identifying patients at a higher risk for relapse. Morin G; Mageau A; Benali K; Bertinchamp R; Piekarski E; Raimbourg Q; Alexandra JF; Goulenok T; van Gysel D; Papo T; Sacre K Eur J Intern Med; 2019 Apr; 62():67-71. PubMed ID: 30711361 [TBL] [Abstract][Full Text] [Related]
34. Retroperitoneal fibrosis. Steroid treatment response seems to depend on its association to IgG4 related disease. Soriano Rios A; Paredes H; Hernández-Calleros J; Uscanga-Domínguez L; Peláez-Luna M Med Hypotheses; 2019 Jan; 122():120-123. PubMed ID: 30593393 [TBL] [Abstract][Full Text] [Related]
35. MR-guided biopsies of lesions in the retroperitoneal space: technique and results. Zangos S; Eichler K; Wetter A; Lehnert T; Hammerstingl R; Diebold T; Reichel P; Herzog C; Hansmann ML; Mack MG; Vogl TJ Eur Radiol; 2006 Feb; 16(2):307-12. PubMed ID: 16059677 [TBL] [Abstract][Full Text] [Related]
36. Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent "scar" ? A study using 18F-fluorodeoxyglucose positron emission tomography. Vaglio A; Greco P; Versari A; Filice A; Cobelli R; Manenti L; Salvarani C; Buzio C Clin Exp Rheumatol; 2005; 23(2):231-4. PubMed ID: 15895895 [TBL] [Abstract][Full Text] [Related]
37. Disease activity and vascular involvement in retroperitoneal fibrosis: first experience with fully integrated 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging compared to clinical and laboratory parameters. Thuermel K; Einspieler I; Wolfram S; Moog P; Meier R; Schwaiger M; Heemann U Clin Exp Rheumatol; 2017; 35 Suppl 103(1):146-154. PubMed ID: 27974103 [TBL] [Abstract][Full Text] [Related]
39. Retroperitoneal xanthogranuloma in a patient with Erdheim-Chester disease. Eble JN; Rosenberg AE; Young RH Am J Surg Pathol; 1994 Aug; 18(8):843-8. PubMed ID: 8037299 [TBL] [Abstract][Full Text] [Related]